2162 Stock Overview
Everjoy Health Group Co., Ltd. engages in the research, development, production, and sale of ceramic tiles in China.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Everjoy Health Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.50 |
52 Week High | CN¥5.28 |
52 Week Low | CN¥3.03 |
Beta | 0.74 |
1 Month Change | -11.17% |
3 Month Change | -4.11% |
1 Year Change | -16.47% |
3 Year Change | -47.53% |
5 Year Change | 2.04% |
Change since IPO | -53.17% |
Recent News & Updates
Everjoy Health Group's (SZSE:002162) Solid Earnings Are Supported By Other Strong Factors
Apr 05Everjoy Health Group Co., Ltd.'s (SZSE:002162) Price Is Out Of Tune With Revenues
Mar 02Shareholder Returns
2162 | CN Building | CN Market | |
---|---|---|---|
7D | 0.9% | 5.2% | 3.1% |
1Y | -16.5% | -18.8% | -13.1% |
Return vs Industry: 002162 exceeded the CN Building industry which returned -18.8% over the past year.
Return vs Market: 002162 underperformed the CN Market which returned -13.1% over the past year.
Price Volatility
2162 volatility | |
---|---|
2162 Average Weekly Movement | 7.5% |
Building Industry Average Movement | 9.1% |
Market Average Movement | 8.6% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002162's share price has been volatile over the past 3 months.
Volatility Over Time: 002162's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 899 | Jing Yu | www.everjoyhealth.com |
Everjoy Health Group Co., Ltd. engages in the research, development, production, and sale of ceramic tiles in China. It also offers medical services; and invests in and leases real estate properties. The company was founded in 1993 and is based in Shanghai, China.
Everjoy Health Group Co., Ltd. Fundamentals Summary
2162 fundamental statistics | |
---|---|
Market cap | CN¥3.24b |
Earnings (TTM) | CN¥44.72m |
Revenue (TTM) | CN¥1.28b |
72.5x
P/E Ratio2.5x
P/S RatioIs 2162 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2162 income statement (TTM) | |
---|---|
Revenue | CN¥1.28b |
Cost of Revenue | CN¥1.02b |
Gross Profit | CN¥260.21m |
Other Expenses | CN¥215.49m |
Earnings | CN¥44.72m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.048 |
Gross Margin | 20.36% |
Net Profit Margin | 3.50% |
Debt/Equity Ratio | 52.6% |
How did 2162 perform over the long term?
See historical performance and comparison